Precision Urological Care: Optical Internal Urethrotomy by MyMedicPlus Experts — Cost, Top Hospitals & Success Rates | MyMedicPlus

Optical Internal Urethrotomy (OIU) is a minimally invasive endoscopic procedure designed to treat urethral strictures — abnormal narrowings of the urethra caused by scar tissue (fibrosis). The urethra is the tube that carries urine from the bladder out of the body, and any narrowing can significantly impede urinary flow, leading to pain, infection, and bladder dysfunction.

During OIU, the urologist introduces a rigid or semi-rigid urethroscope (cystoscope) through the urethral meatus under direct visual guidance. Once the stricture is identified, a cold knife or holmium laser is used to precisely incise (cut) the scar tissue, allowing the urethral lumen to widen and restoring normal urine flow. The procedure is performed under anaesthesia and typically takes 15–45 minutes as a day-case or short-stay procedure.

First described in the 1970s and refined over subsequent decades, OIU remains one of the most widely performed procedures for short-segment (<2 cm) bulbar urethral strictures. It is favoured for its simplicity, low perioperative risk, and rapid recovery compared with open surgical alternatives. However, clinicians must counsel patients that stricture recurrence rates are significant — approximately 30–50% within the first two years — and repeat procedures or definitive urethroplasty may be required.

OIU is primarily indicated for urethral stricture disease, a condition in which cicatricial (scar) tissue narrows the urethra. Strictures may arise from multiple causes:

• Inflammatory / Infectious: Gonorrhoeal urethritis was historically the leading cause; non-gonococcal urethritis (Chlamydia, Mycoplasma) and lichen sclerosus (balanitis xerotica obliterans) also produce dense fibrosis.
• Traumatic: Blunt perineal or pelvic trauma, pelvic fracture urethral injuries (PFUI), and straddle injuries disrupt urethral tissue and trigger scarring during healing.
• Iatrogenic: Prolonged catheterisation, prior urethral instrumentation, transurethral resection of the prostate (TURP), or brachytherapy for prostate cancer can damage the urethral epithelium.
• Post-hypospadias repair: Strictures at anastomosis sites following hypospadias corrective surgery in children or adults.
• Idiopathic: Approximately 30% of cases have no identifiable cause but likely reflect unrecognised subclinical trauma or infection.

OIU is most effective for short (<2 cm), single, bulbar urethral strictures without extensive spongiofibrosis (scarring of surrounding erectile tissue). It is less effective for long, complex, penile, or recurrent strictures, where urethroplasty is strongly preferred.

Patient selection is critical to achieving durable outcomes. A urologist will evaluate candidacy based on clinical, endoscopic, and imaging findings:

Ideal Candidates

• Men with a first-occurrence, short (<2 cm) bulbar urethral stricture confirmed on retrograde urethrogram (RUG) and/or urethroscopy
• Patients with moderate-to-severe lower urinary tract symptoms (LUTS) attributable to a confirmed stricture
• Patients who are not suitable for or decline open urethroplasty
• Those who require a temporary solution while planning definitive surgery

Relative Contraindications

• Strictures longer than 2 cm or involving the penile urethra (higher recurrence rates)
• Dense spongiofibrosis on ultrasonography (peri-urethral fibrosis predicts poor OIU outcomes)
• Active urinary tract infection (UTI) — treat infection before any instrumentation
• Uncorrected coagulopathy or anticoagulant therapy not bridged appropriately
• Prior failed OIU (multiple failed incisions significantly worsen subsequent surgical planes)

Pre-operative workup typically includes urinalysis and urine culture, uroflowmetry, post-void residual measurement, retrograde urethrogram, and occasionally flexible cystoscopy or sonourethrogram to map stricture length and degree of spongiofibrosis.

Several technical variants of OIU exist, each with specific advantages:

Cold Knife (Sharp) Urethrotomy

The classic technique uses a direct-vision internal urethrotome (Sachse urethrotome or equivalent) to make one or multiple incisions at the 12 o'clock position (and sometimes at 4 and 8 o'clock) through the stricture under direct vision. It avoids thermal tissue injury and remains the most widely used method globally.

Holmium Laser Urethrotomy

Holmium:YAG laser energy (wavelength 2,140 nm) vaporises scar tissue with a shallow depth of penetration (0.4 mm), providing precise incision with excellent haemostasis. Studies suggest laser urethrotomy may reduce peri-urethral bleeding and potentially improve short-term outcomes compared to cold knife in select cases, though long-term recurrence rates appear comparable.

Adjuvant Mitomycin C (MMC) Application

Mitomycin C is an antimetabolite that inhibits fibroblast proliferation and collagen synthesis. Application at the incision site immediately after OIU (via a soaked sponge or direct injection) aims to reduce scar tissue reformation. Evidence from randomised controlled trials is mixed, but some studies demonstrate improved recurrence-free intervals at 12–24 months, particularly for short bulbar strictures.

Adjuvant Intralesional Steroid Injection

Triamcinolone or similar corticosteroids injected into the incised stricture may modulate fibroblast activity. Early evidence is promising but larger randomised trials are needed before this becomes standard of care.

Post-OIU Clean Intermittent Self-Catheterisation (CISC)

Regular self-dilation using clean intermittent catheterisation (typically a 14–16 Fr catheter) in the weeks following OIU may help maintain urethral patency, particularly in higher-risk patients with prior recurrence.

OIU offers several meaningful clinical advantages, particularly as a first-line treatment for suitable strictures:

• Minimally Invasive: No external incisions are made; the procedure is entirely transurethral, avoiding the morbidity of open perineal surgery.
• Short Operative Time: The procedure typically takes 15–45 minutes, allowing day-case treatment in the majority of patients and reducing hospital resource utilisation.
• Rapid Recovery: Most patients return to normal activity within 1–2 weeks. There is no wound care, and most can resume light work within days of the procedure.
• Effective Symptom Relief: OIU rapidly restores urinary flow in most patients, with measurable improvements in maximum flow rate (Qmax) and International Prostate Symptom Score (IPSS) within weeks.
• Repeatable: In patients who are not surgical candidates for open urethroplasty, OIU can be repeated, providing ongoing symptomatic relief even if long-term cure is not achieved.
• Low Perioperative Risk: Serious intraoperative complications are uncommon. The procedure carries minimal blood loss, and anaesthetic risk is low for a short procedure.
• Preserves Future Options: A well-performed OIU does not significantly compromise the surgical planes required for subsequent urethroplasty, preserving the option of definitive repair.
• Cost-Effective Entry Treatment: As a day-case procedure, OIU is substantially less costly than open urethroplasty, making it a reasonable first-line choice when recurrence risk is acceptable.

Patients must be counselled thoroughly about OIU risks before consenting. Complications can be early (perioperative) or late (post-procedure):

Early Complications

• Urinary Tract Infection: The most common early complication. Pre-operative urine culture is essential; prophylactic antibiotics are routinely administered at induction.
• Bleeding / Haematuria: Mild-to-moderate blood in the urine is expected for several days. Significant haemorrhage requiring transfusion is rare (<1%) but possible.
• Urethral False Passage: Aggressive or blind instrumentation can perforate the urethral wall, creating a false passage. This risk is minimised with optical guidance.
• Urinary Extravasation: Deep incision into the corpus spongiosum can cause urine to extravasate into peri-urethral tissues, potentially leading to sepsis.
• Anaesthetic Risks: Standard risks of general or spinal anaesthesia apply.

Late Complications

• Stricture Recurrence (Most Significant): Recurrence rates are 30–50% at 12 months and rise with subsequent procedures. Each re-do OIU further worsens spongiofibrosis, increasing stricture complexity. After two failed OIUs, guidelines recommend definitive urethroplasty.
• Erectile Dysfunction: Rare but reported, particularly with deep incisions at 3 and 9 o'clock positions damaging cavernous nerve branches or pudendal vessels.
• Urinary Incontinence: Very rare; more a concern with proximal (membranous) strictures near the external sphincter.
• Urethral Fistula: Uncommon but serious; requires surgical repair.

Structured follow-up after OIU is critical to detect recurrence early and optimise long-term outcomes.

Immediate Post-Procedure Care

A urethral catheter (14–16 Fr) is typically left in place for 24–72 hours after the procedure to allow the incised mucosa to heal in an open position. Patients are discharged once voiding satisfactorily and haematuria has subsided. Antibiotic prophylaxis is maintained for 3–5 days per local protocol.

Short-Term Recovery (1–4 Weeks)

• Mild dysuria, frequency, and haematuria are expected for the first 1–2 weeks
• Patients are advised to drink 2–3 litres of fluid daily to maintain good urine output and reduce clot formation
• Strenuous physical activity should be avoided for 2–4 weeks
• If CISC has been prescribed, the nurse or specialist will train the patient before discharge

Surveillance Schedule

Most urologists recommend uroflowmetry at 3, 6, and 12 months post-OIU, then annually. A sustained Qmax >15 mL/s is a reassuring indicator of urethral patency. Declining flow rates on serial assessments should prompt early flexible cystoscopy or urethrogram to evaluate recurrence before complete obliteration.

Long-Term Considerations

Patients with recurrent strictures should be counselled about the superior long-term success rates of substitution urethroplasty (buccal mucosal graft urethroplasty achieves >80–90% patency at 5 years). Delaying definitive surgery through repeated OIU can progressively worsen stricture anatomy and surgical complexity.

The cost of OIU varies considerably depending on the healthcare setting, country, and whether the procedure is performed in a public or private facility.

Global Cost Ranges (Approximate)

• India: USD 500–1,500 — highly cost-effective at JCI/NABH accredited centres with internationally trained urologists
• Thailand: USD 1,000–2,500 — modern facilities, shorter waiting times
• Turkey: USD 800–2,000 — growing medical tourism hub with skilled urologists
• United Kingdom (Private): GBP 2,000–4,000 — NHS waiting lists can be prolonged
• United States: USD 5,000–15,000 — highly variable by insurance status and facility
• Australia: AUD 3,000–8,000 in private setting

Factors Affecting Cost

• Technique: Laser urethrotomy incurs higher equipment costs than cold knife
• Adjuvant therapy: Mitomycin C application adds to procedural cost
• Anaesthesia type: General anaesthesia costs more than local or sedation
• Hospital grade: Accredited tertiary centres charge more than community hospitals
• Surgeon experience: High-volume reconstructive urologists may charge premium fees
• Post-operative investigations: Uroflowmetry and imaging during surveillance add to total treatment cost

Patients travelling internationally for OIU should factor in accommodation, travel, post-operative stay (typically 3–5 days before flying), and travel insurance that covers surgical procedures. Use MyMedicPlus to compare accredited hospitals and request personalised cost estimates.

OIU is one of several options for managing urethral strictures. The right choice depends on stricture characteristics, patient health, prior treatments, and patient preference:

Urethral Dilation

Sequential mechanical dilation using progressively larger bougies or balloon catheters widens the strictured segment without incision. It is the oldest and simplest intervention but carries the highest recurrence rates and risk of creating false passages. Dilation is now generally reserved for patients unable to undergo OIU or as a temporising measure.

Urethroplasty (Open Reconstruction)

Considered the gold standard for definitive treatment, urethroplasty involves excision and primary anastomosis (EPA) for short strictures or graft/flap augmentation for longer or complex strictures. Buccal mucosal graft (BMG) urethroplasty achieves long-term success rates of 80–95% at 5 years. It requires an open perineal incision, general anaesthesia, longer hospital stay (2–4 days), and 4–6 weeks recovery, but offers far superior durability than OIU for recurrent or complex disease.

Urethral Stenting (Urolume / Memotherm)

Permanent metallic stents placed endoscopically can maintain urethral patency without ongoing dilation. However, high rates of stent migration, encrustation, hyperplastic tissue ingrowth, and difficult salvage procedures have limited their use to poor surgical candidates or patients with spinal cord injury.

Clean Intermittent Self-Catheterisation (CISC)

Regular self-catheterisation can manage urinary retention caused by strictures in patients who are not surgical candidates. It prevents acute urinary retention but does not treat the underlying stricture. Long-term CISC carries risks of UTI and urethral trauma.

Conservative Watchful Waiting

Appropriate only for patients with mild symptoms, good flow rates, and no upper tract involvement. Patients require regular monitoring for deterioration, obstructive uropathy, or infection.